Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugatesBen‐Quan Shen, Jagath R. Junutula, Jakub Baudys et al.|Nature Biotechnology|2012Cited by 997
Mapping the NPHP-JBTS-MKS Protein Network Reveals Ciliopathy Disease Genes and PathwaysLiyun Sang, Peter K. Jackson, Julie J. Miller et al.|Cell|2011Cited by 623
SNARE Complex Formation Is Triggered by Ca 2+ and Drives Membrane FusionYu A. Chen, Richard H. Scheller, Suzie J. Scales et al.|Cell|1999Cited by 412
Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug SelectionAndrew G. Polson, Allen Ebens, Jill Calemine-Fenaux et al.|Cancer Research|2009Cited by 248
Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphomaAndrew G. Polson, Allen Ebens, Shang‐Fan Yu et al.|Blood|2007Cited by 172